Observational Study to Assess Migraine Prediction Tool

Paused

Conditions studied: Migraine

In brief

This is a prospective, observational study. The participant will be required to approve his/her participation in the study by completing the electronic consent form. Data collected within the first eight weeks (weeks 1-8) will be used to develop the prediction models (either personal or population/group models). The developed algorithm will be freezer and tested against the data collected during weeks 1-8 of a different cohort population

Key facts

Study ID

NCT05523310

Run by

Theranica

People needed

200

Starts

2030-01-01

Expected to finish

2030-11-15

Last updated by the study team

2024-11-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject age 18-75 years.
• Subject has migraine diagnosis for over 6 months prior to enrolling to the study.
• Subject has 4-24 headache days per month.
• Subject has a Nerivio user account, or willing to create a Nerivio user account to participate in the study.
• Subject is willing to sign an Informed Consent Form.

You may not qualify if…

• NA

Where it is running

• Westport Headache Institute — Westport, Connecticut, United States
• Headache Neurology Research Institute — Ridgeland, Mississippi, United States
• Nuvance Health Vassar Medical Center — Poughkeepsie, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.